Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Spinal Cord Neoplasms 1Pinealoma 1Neuroma, Acoustic 1Neoplasms, Germ Cell and Embryonal 1Meningioma 1Medulloblastoma 1Glioma 1Glioblastoma 1Ependymoma 1Craniopharyngioma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 18Etoposide 12Cisplatin 11Temozolomide 10Vincristine 9Radiotherapy 9Magnetic Resonance Spectroscopy 9Filgrastim 8Irinotecan 7Carboplatin 7X-Rays 6Phantoms, Imaging 6Topotecan 5Specimen Handling 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Thiotepa 4Radiation 4Lomustine 4Biopsy 4Bevacizumab 4tipifarnib 3sargramostim 3palbociclib 3Methotrexate 3HhAntag691 3Chemotherapy, Adjuvant 3ulixertinib 2tazemetostat 2sonidegib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Medulloblastoma × tozuleristide × Clear all
NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Cedars-Sinai Medical Center

Phase 2 Completed
50 enrolled
CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡